BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30
• 31

• Job Trends

  Biotechnology Company Plans Long-Term Growth, R&D in Central Indiana

  B2S Life Sciences announced plans today to expand its operations in Johnson County, creating up to 23 new, high-wage jobs by 2020.

  March 8, 2018

   · 

  4 min read
• Stem Cell Therapy for Multiple Sclerosis - A Pipeline Analysis | Technavio

  Technavio has announced their latest report on stem cell therapy for multiple sclerosis for the period 2018-2022

  March 8, 2018

   · 

  2 min read
• BioMidwest

  Option Care Selected as the Home and Alternate Site Infusion Provider for Newly Approved Breakthrough Therapy, Trogarzo™ (ibalizumab-uiyk) Injection

  Option Care Enterprises, Inc. has been selected by Theratechnologies Inc. as an infusion provider for Trogarzo™ (ibalizumab-uiyk) Injection, an intravenous (IV) infusion for the treatment of multidrug resistant human immunodeficiency virus type 1 (HIV-1) infections.

  March 8, 2018

   · 

  3 min read
• Biotech Beach

  Quidel Announces Private Exchange Transactions

  Pursuant to these exchange agreements Quidel will exchange approximately $67.656 million in aggregate principal amount of the 2020 Notes.

  March 8, 2018

   · 

  3 min read
• Biotech Bay

  SentreHEART Announces Participation at The American College of Cardiology’s 67th Annual Scientific Session & Expo

  SentreHEART, Inc., the manufacturer of the LARIAT® Suture Delivery Device (LARIAT) will be participating in the American College of Cardiology (ACC) 2018 meeting being held in Orlando, Florida, March 10-12, 2018.

  March 8, 2018

   · 

  2 min read
• Business

  Audentes Therapeutics Reports Fourth Quarter 2017 and Full Year Financial Results and Provides Corporate Update

  Audentes Therapeutics Inc. reported its financial results for the fourth quarter and full year ended December 31, 2017 and provided an update on the company’s recent achievements and anticipated upcoming milestones.

  March 8, 2018

   · 

  5 min read
• Business

  BioLife Solutions Announces Fourth Quarter and Full Year 2017 Financial Results

  BioLife Solutions, Inc. reported financial results and operational highlights for the three and 12 months ended December 31, 2017.

  March 8, 2018

   · 

  6 min read
• Business

  AcelRx Pharmaceuticals Reports Fourth Quarter 2017 Financial Results

  AcelRx Pharmaceuticals Inc. reported fourth quarter 2017 financial results.

  March 8, 2018

   · 

  4 min read
• Business

  CytoSorbents Achieves Record Revenue and Product Sales Growth in 2017

  CytoSorbents Corporation achieves record total revenue, CytoSorb sales, and product gross margins in 2017.

  March 8, 2018

   · 

  11 min read
• FDA

  TherapeuticsMD Announces FDA Acceptance of New Drug Application (NDA) and Prescription Drug User Fee Act (PDUFA) Date for TX-001HR

  TherapeuticsMD, Inc. announced the acceptance of the NDA for TX-001HR by the U.S. Food and Drug Administration (FDA).

  March 8, 2018

   · 

  2 min read